{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T21:46:18Z","timestamp":1770759978618,"version":"3.50.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.ijantimicag.2004.08.018","type":"journal-article","created":{"date-parts":[[2005,1,8]],"date-time":"2005-01-08T23:55:22Z","timestamp":1105228522000},"page":"168-172","source":"Crossref","is-referenced-by-count":28,"title":["Clarithromycin co-administered with amikacin attenuates systemic inflammation in experimental sepsis with Escherichia coli"],"prefix":"10.1016","volume":"25","author":[{"given":"Evangelos J.","family":"Giamarellos-Bourboulis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fotini","family":"Baziaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasia","family":"Antonopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pantelis","family":"Koutoukas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vassilios","family":"Kousoulas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lambros","family":"Sabracos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charalambos","family":"Panagou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Despina","family":"Perrea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Giamarellou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2004.08.018_bib1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1128\/AAC.48.1.93-99.2004","article-title":"Immunomodulatory clarithromycin treatment of experimental sepsis and acute pyelonephritis caused by multidrug-resistant Pseudomonas aeruginosa","volume":"48","author":"Giamarellos-Bourboulis","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.018_bib2","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/jac\/dkf008","article-title":"Clarithromycin suppresses lipopolysaccharide-induced interleukin-8 production by human monocytes through AP-1 and NF-kappa B transcription factors","volume":"49","author":"Kikuchi","year":"2002","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 1","key":"10.1016\/j.ijantimicag.2004.08.018_bib3","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1007\/s001340000574","article-title":"Immunological therapies for sepsis","volume":"27","author":"Arndt","year":"2001","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2004.08.018_bib4","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1084\/jem.192.6.881","article-title":"Interleukin 8 receptor deficiency confers susceptibility to acute experimental pyelonephritis and may have a human counterpart","volume":"192","author":"Frend\u00e9us","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.ijantimicag.2004.08.018_bib5","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/jac\/47.5.617","article-title":"In vivo efficacy of continuous infusion versus intermittent dosing of ceftazidime alone or in combination with amikacin relative to human kinetic profiles in a Pseudomonas aeruginosa rabbit endocarditis model","volume":"47","author":"Robaux","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.018_bib6","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1086\/514005","article-title":"Serotype-related differences in inflammatory response to Streptococcus pneumoniae in experimental meningitis","volume":"175","author":"Engelhard","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2004.08.018_bib7","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s11745-999-0416-2","article-title":"Dose-dependent inhibition of cell proliferation induced by lipid peroxidation products in rat hepatoma cells after enrichment with arachidonic acid","volume":"34","author":"Muzio","year":"1999","journal-title":"Lipids"},{"key":"10.1016\/j.ijantimicag.2004.08.018_bib8","series-title":"Antibiotics in laboratory medicine","first-page":"295","article-title":"Measurement of antibiotics in human body fluids: techniques and significance","author":"Chapin-Robinson","year":"1991"},{"key":"10.1016\/j.ijantimicag.2004.08.018_bib9","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1086\/339549","article-title":"Clinical trials of immunomodulatory therapies in severe sepsis and septic shock","volume":"34","author":"Vincent","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2004.08.018_bib10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0014-2999(01)01321-8","article-title":"Anti-inflammatory effects of macrolide antibiotics","volume":"429","author":"Culic","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.ijantimicag.2004.08.018_bib11","first-page":"156","article-title":"Anti-inflammatory activity of macrolide antibiotics","volume":"292","author":"Ianaro","year":"2000","journal-title":"J Pharmacol Exper Toxicol"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857904004145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857904004145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T04:57:17Z","timestamp":1548824237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857904004145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0924857904004145"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2004.08.018","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}